Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis

Hong Qi ZHANG*, Yu Fung Yau, Kit Ying Szeto, Wai Tak Chan, Jack Wong, Min LI

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

9 Citations (Scopus)


Pulmonary fibrosis (PF) is a restrictive lung disease that may occur idiopathically or as a complication of many diseases. The outcome of the current treatment by glucocorticoids remains very unsatisfactory. This study has tested a new Chinese medicine formula DSQRL for the treatment of experimental PF in comparison with prednisone. Seventy-two rats with PF induced by CCl4 were randomly divided into four groups to undertake the treatment of either (a) high dose of prednisone; (b) Chinese medicine formula DSQRL; (c) combined treatment of the above two; or (d) tap water of the same volume. At the end of 30 days treatment, the DSQRL treatment achieved a better outcome (p < 0.05) than prednisone in terms of histological examination, bronchoalveolar lavage fluid analysis, hydroxyproline assay and complications. The observations support further investigation and clinical trials of this Chinese medicinal formula for the treatment of PF.

Original languageEnglish
Pages (from-to)543-546
Number of pages4
JournalJournal of Ethnopharmacology
Issue number3
Publication statusPublished - 12 Feb 2007

Scopus Subject Areas

  • Pharmacology
  • Drug Discovery

User-Defined Keywords

  • Chinese medicine
  • Prednisone
  • Pulmonary fibrosis
  • Rat


Dive into the research topics of 'Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this